四环医药 is focused on medical aesthetics and innovative biopharmaceuticals, offering a diversified product portfolio covering areas such as medical aesthetics, oncology, metabolism, diabetes, cardiovascular diseases, and modern traditional Chinese medicine/industrial hemp.

四环医药

Sihuan Pharmaceutical Holdings Group | 389 followers on LinkedIn. 四环医药控股集团有限公司成立于2001年，经过十余年的发展，现已成为中国医院处方药市场位列第四的领先制药企业，就市场份额而言，已成为全国最大的心脑血管处方药物供货商。四环医药的成功源于其拥有独特的销售模式、领先市场的产品组合、覆盖全国的网络及雄厚的研发能力。

Sihuan Pharmaceutical Holdings Group - analytical manager

Qin Li

Sihuan Pharmaceutical Holdings Group - Medical Manager/Cosmetic Surgeon

Leon Lei

Sihuan Pharmaceutical Holdings Group

XuanPu Li

Sihuan Pharmaceutical Holdings Group-Chief of Staff

于一

Viewport Meta

IPhone / Mobile Compatible

Euro

Google Tag Manager

Google Analytics

DNSSEC

Content Delivery Network

Global Site Tag

Mobile Non Scaleable Content

nginx

Che Fengsheng

Chairman

Manufacturing Public Companies With More Than 1000 Employees

China Companies With More Than 100 Employees (Top 10K)

Beijing Companies

Companies that Went Public in 2010

Sihuan Pharmaceutical Holdings Group Ltd. has achieved sound development in the past years and has grown into the leading pharmaceutical company in China’s prescription drug market. The Group has been the largest cardio-cerebral vascular drug franchise in China’s prescription drug market since 2007. The success of the Group can be attributed to its unique and proven sales & marketing model, extensive nationwide distribution network, diversified portfolio of market-leading drugs, and strong research & development capabilities.

Beijing

China

Asia

Sihuan Pharmaceutical

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the in...

Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd.

Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads Investment in Xuanzhu Biopharm

Sihuan Pharmaceutical Launched an Equity Incentive Plan to Inject New Impetus for the Company's Growth

BRIEF—China’s Sihuan collaborates with Hetero Drugs

Strides Pharma enters China via JV with Sihuan Pharmaceutical

Taiwan

Singapore

Azerbaijan

Philippines

India

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

Sihuan Pharmaceutical Holdings Group Ltd.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 8:45 PM	ffc57dd3
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 8:45 PM	fed0178b
crunchbase trigger	general	Nov 17, 2024 8:45 PM	0b3e877d
crunchbase profile	general	Nov 17, 2024 9:05 PM	3f0e4d04
li profile	general	Nov 17, 2024 8:45 PM	babea071
translate crunchbase fundingrounds	general	Nov 17, 2024 9:30 PM	d5dce33e
peers	general	Nov 17, 2024 8:45 PM	155e5ad8
news basic	general	Nov 17, 2024 8:45 PM	38209f45
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

0460

COM:SIHUANPHARM

四环医药

Last Close

0.70

22/11 08:08

Market Cap

5.20B

Beta: -

Volume Today

17.55M

Avg: -